This interview examines the use of KIR genotyping during donor selection and its association with improved outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation.
Katy Rezvani, MD, PhD
Advertisement
Articles by Katy Rezvani, MD, PhD
Advertisement
Latest Updated Articles
Using KIR Genotyping to Improve Transplant SuccessJanuary 5th 2017
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Ruxolitinib Tablets for Hematologic Malignancies
2
FDA Permits Expanded Daraxonrasib Access in Previously Treated Metastatic PDAC
3
Unraveling Daraxonrasib’s Breakthrough in Metastatic Pancreatic Cancer
4
Precision Medicine and the “Slow Death” of Transplant in Lymphoma
5